📰 Device Exemption News
Page 5 - Device Exemption News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Device Exemption. Real-time updates on events, politics, business and more.
October 20, 2022
Surat (Gujarat) [India], October 20 (ANI/PNN): Concept Medical Inc and its group company Envision Scientific, the world's leading medical device manufacturing company, celebrated their Founder's Day and Azadi Ka Amrit Mahotsav on Tuesday with the 'Mega Voluntary Blood Donation Camp' at all three of their facilities, including Asia's largest medical device manufacturing unit in the Surat Special Economic Zone (SurSEZ). Paresh Patel, Chairman of the Surat Municipal Corporation&...
October 11, 2022
Last minute, squeaky clean! After years of planning, negotiation, and input, the user fee reauthorization bill was passed and signed into law on the...
October 6, 2022
/PRNewswire/ -- Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of...
October 6, 2022
Last minute, squeaky clean! After years of planning, negotiation, and input, the user fee reauthorization bill was passed and signed into law on the...
August 12, 2022
Avenda Health Receives FDA Investigational Device Exemption (IDE) for its AI-Enabled prostate cancer therapy, FocalPoint ablation system
August 11, 2022
SELUTION SLR, MedAlliance\'s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femoral artery (SFA).
August 10, 2022
GENEVA, Aug. 10, 2022 /PRNewswire/ -- SELUTION SLR, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its
August 10, 2022
Geneva [Switzerland], August 10 (ANI/PRNewswire): SELUTION SLR, MedAlliances novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femoral artery (SFA).
August 10, 2022
Get latest articles and stories on Business at LatestLY. SELUTION SLR™, MedAlliances novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femoral artery (SFA). Business News | MedAlliance SELUTION SLR Receives Second FDA IDE Approval.
August 9, 2022
GENEVA, Aug. 9, 2022 /PRNewswire/ -- SELUTION SLR™, MedAlliances novel sirolimus-eluting balloon, has received conditional FDA Investigational De...